This inventor holds 1 USPTO granted patent. Top assignee: Ambit Biosciences Corporation. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Rathan Prasad Achampeta: Innovator in Pharmaceutical Chemistry
Introduction
Rathan Prasad Achampeta is a notable inventor based in Secunderabad, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. His work focuses on creating innovative solutions for treating various diseases.
Latest Patents
Rathan Prasad Achampeta holds a patent for a process related to the preparation of imidazo[2,1-B][1,3]benzothiazole derivatives. The patent details a method for synthesizing N-(5-tert-butyl-isoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-B][1,3]benzothiazol-2-yl]phenyl}urea, which is useful for treating, preventing, and managing diseases such as proliferative diseases, FLT-3 mediated diseases, and cancers. This compound can exist in various forms, including pharmaceutically acceptable salts, solvates, hydrates, or polymorphs.
Career Highlights
Rathan Prasad Achampeta is currently associated with Ambit Biosciences Corporation, where he continues to advance his research and development efforts. His innovative approach to pharmaceutical chemistry has positioned him as a key player in the industry.
Collaborations
Rathan has collaborated with notable colleagues, including Timothy David Gross and Janakiram Rao Citineni. These partnerships have further enhanced his research capabilities and contributed to the success of his projects.
Conclusion
Rathan Prasad Achampeta is a distinguished inventor whose work in pharmaceutical chemistry has the potential to impact the treatment of various diseases significantly. His innovative contributions and collaborations highlight his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
